IOVS
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Rungger–Brändle, E.
Right arrow Articles by Leuenberger, P. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Rungger–Brändle, E.
Right arrow Articles by Leuenberger, P. M.
(Investigative Ophthalmology and Visual Science. 2000;41:1971-1980.)
© 2000 by The Association for Research in Vision and Ophthalmology, Inc.

Glial Reactivity, an Early Feature of Diabetic Retinopathy

Elisabeth Rungger–Brändle, André A. Dosso and Peter M. Leuenberger

From the Cell Biology Laboratory, University Eye Clinic, Geneva, Switzerland.

PURPOSE. To characterize early structural gliotic reactions in retinal Müller cells, astrocytes, and microglia in experimentally induced diabetes.

METHODS. Rats were rendered diabetic by streptozotocin injection and killed after 2, 4, 12, or 20 weeks. Cell densities were determined in flatmounted retinas or transverse semithin sections. Expression of glial fibrillary acidic protein (GFAP) was localized on frozen sections or flatmounts by immunofluorescence and confocal microscopy, and GFAP content was evaluated by Western blot analysis. Microglial cells were visualized by binding of isolectin B4 or staining with antibodies to phosphotyrosine residues. The integrity of the blood–retinal barrier was assessed by intravenous injection of Evans blue.

RESULTS. The density of Müller cells and microglia was significantly increased at 4 weeks of diabetes compared with nondiabetic controls. GFAP expression in Müller cells was not detected at 4 weeks but was prominent at 12 weeks. The number of astrocytes was significantly reduced at 4 weeks in the peripapillary and far peripheral retina. Shape changes of microglial cells indicated functional activation. Leakage of the blood–retinal barrier was observed at 2 weeks of hyperglycemia, the earliest time point investigated.

CONCLUSIONS. The leakage of the blood–retinal barrier before glial reactivity suggests that glia are early targets of vascular hyperpermeability. The individual glial cell types react differentially to the diabetic state. Müller cells undergo hyperplasia preceding GFAP expression, and microglial cells are activated, whereas astrocytes regress. This glial behavior may contribute decisively to the onset and development of neuropathy in the diabetic retina.




This article has been cited by other articles:


Home page
Arch OphthalmolHome page
H.-y. Zeng, W. R. Green, and M. O. M. Tso
Microglial Activation in Human Diabetic Retinopathy
Arch Ophthalmol, February 1, 2008; 126(2): 227 - 232.
[Abstract] [Full Text] [PDF]


Home page
IOVSHome page
K. W. Bronson-Castain, M. A. Bearse Jr, Y. Han, M. E. Schneck, S. Barez, and A. J. Adams
Association between Multifocal ERG Implicit Time Delays and Adaptation in Patients with Diabetes
Invest. Ophthalmol. Vis. Sci., November 1, 2007; 48(11): 5250 - 5256.
[Abstract] [Full Text] [PDF]


Home page
IOVSHome page
P. deS. Senanayake, J. Drazba, K. Shadrach, A. Milsted, E. Rungger-Brandle, K. Nishiyama, S.-I. Miura, S. Karnik, J. E. Sears, and J. G. Hollyfield
Angiotensin II and Its Receptor Subtypes in the Human Retina
Invest. Ophthalmol. Vis. Sci., July 1, 2007; 48(7): 3301 - 3311.
[Abstract] [Full Text] [PDF]


Home page
DiabetesHome page
J. A. Vincent and S. Mohr
Inhibition of Caspase-1/Interleukin-1{beta} Signaling Prevents Degeneration of Retinal Capillaries in Diabetes and Galactosemia
Diabetes, January 1, 2007; 56(1): 224 - 230.
[Abstract] [Full Text] [PDF]


Home page
DiabetesHome page
D. A. Antonetti, A. J. Barber, S. K. Bronson, W. M. Freeman, T. W. Gardner, L. S. Jefferson, M. Kester, S. R. Kimball, J. K. Krady, K. F. LaNoue, et al.
Diabetic Retinopathy: Seeing Beyond Glucose-Induced Microvascular Disease
Diabetes, September 1, 2006; 55(9): 2401 - 2411.
[Abstract] [Full Text] [PDF]


Home page
IOVSHome page
S. Saraswathy, G. Wu, and N. A. Rao
Retinal microglial activation and chemotaxis by docosahexaenoic Acid hydroperoxide.
Invest. Ophthalmol. Vis. Sci., August 1, 2006; 47(8): 3656 - 3663.
[Abstract] [Full Text] [PDF]


Home page
IOVSHome page
J. A. Phipps, P. Yee, E. L. Fletcher, and A. J. Vingrys
Rod photoreceptor dysfunction in diabetes: activation, deactivation, and dark adaptation.
Invest. Ophthalmol. Vis. Sci., July 1, 2006; 47(7): 3187 - 3194.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Pathol.Home page
A. A. Kramerov, M. Saghizadeh, H. Pan, A. Kabosova, M. Montenarh, K. Ahmed, J. S. Penn, C. K. Chan, D. R. Hinton, M. B. Grant, et al.
Expression of Protein Kinase CK2 in Astroglial Cells of Normal and Neovascularized Retina
Am. J. Pathol., May 1, 2006; 168(5): 1722 - 1736.
[Abstract] [Full Text] [PDF]


Home page
Br. J. Ophthalmol.Home page
A Lecleire-Collet, L H Tessier, P Massin, V Forster, G Brasseur, J A Sahel, and S Picaud
Advanced glycation end products can induce glial reaction and neuronal degeneration in retinal explants
Br. J. Ophthalmol., December 1, 2005; 89(12): 1631 - 1633.
[Abstract] [Full Text] [PDF]


Home page
IOVSHome page
N. S. Umapathy, W. Li, B. A. Mysona, S. B. Smith, and V. Ganapathy
Expression and Function of Glutamine Transporters SN1 (SNAT3) and SN2 (SNAT5) in Retinal Muller Cells
Invest. Ophthalmol. Vis. Sci., November 1, 2005; 46(11): 3980 - 3987.
[Abstract] [Full Text] [PDF]


Home page
IOVSHome page
R. A. Feit-Leichman, R. Kinouchi, M. Takeda, Z. Fan, S. Mohr, T. S. Kern, and D. F. Chen
Vascular Damage in a Mouse Model of Diabetic Retinopathy: Relation to Neuronal and Glial Changes
Invest. Ophthalmol. Vis. Sci., November 1, 2005; 46(11): 4281 - 4287.
[Abstract] [Full Text] [PDF]


Home page
Br. J. Ophthalmol.Home page
C A Westall
Detecting ocular-visual function changes in diabetes
Br. J. Ophthalmol., November 1, 2005; 89(11): 1392 - 1393.
[Full Text] [PDF]


Home page
IOVSHome page
C. J. Layton, G. Chidlow, R. J. Casson, J. P. M. Wood, M. Graham, and N. N. Osborne
Monocarboxylate Transporter Expression Remains Unchanged during the Development of Diabetic Retinal Neuropathy in the Rat
Invest. Ophthalmol. Vis. Sci., August 1, 2005; 46(8): 2878 - 2885.
[Abstract] [Full Text] [PDF]


Home page
IOVSHome page
A. J. Barber, D. A. Antonetti, T. S. Kern, C. E. N. Reiter, R. S. Soans, J. K. Krady, S. W. Levison, T. W. Gardner, and S. K. Bronson
The Ins2Akita Mouse as a Model of Early Retinal Complications in Diabetes
Invest. Ophthalmol. Vis. Sci., June 1, 2005; 46(6): 2210 - 2218.
[Abstract] [Full Text] [PDF]


Home page
DiabetesHome page
J. K. Krady, A. Basu, C. M. Allen, Y. Xu, K. F. LaNoue, T. W. Gardner, and S. W. Levison
Minocycline Reduces Proinflammatory Cytokine Expression, Microglial Activation, and Caspase-3 Activation in a Rodent Model of Diabetic Retinopathy
Diabetes, May 1, 2005; 54(5): 1559 - 1565.
[Abstract] [Full Text] [PDF]


Home page
IOVSHome page
C. Gerhardinger, M. B. Costa, M. C. Coulombe, I. Toth, T. Hoehn, and P. Grosu
Expression of Acute-Phase Response Proteins in Retinal Muller Cells in Diabetes
Invest. Ophthalmol. Vis. Sci., January 1, 2005; 46(1): 349 - 357.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Pathol.Home page
S. X. Zhang, J.-x. Ma, J. Sima, Y. Chen, M. S. Hu, A. Ottlecz, and G. N. Lambrou
Genetic Difference in Susceptibility to the Blood-Retina Barrier Breakdown in Diabetes and Oxygen-Induced Retinopathy
Am. J. Pathol., January 1, 2005; 166(1): 313 - 321.
[Abstract] [Full Text] [PDF]


Home page
DiabetesHome page
C. Guidry, R. Feist, R. Morris, and C. W. Hardwick
Changes in IGF Activities in Human Diabetic Vitreous
Diabetes, September 1, 2004; 53(9): 2428 - 2435.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
M. I. Dorrell, A. Otani, E. Aguilar, S. K. Moreno, and M. Friedlander
Adult bone marrow-derived stem cells use R-cadherin to target sites of neovascularization in the developing retina
Blood, May 1, 2004; 103(9): 3420 - 3427.
[Abstract] [Full Text] [PDF]


Home page
IOVSHome page
C. Guidry, K. M. Bradley, and J. L. King
Tractional Force Generation by Human Muller Cells: Growth Factor Responsiveness and Integrin Receptor Involvement
Invest. Ophthalmol. Vis. Sci., March 1, 2003; 44(3): 1355 - 1363.
[Abstract] [Full Text] [PDF]


Home page
DiabetesHome page
V. Asnaghi, C. Gerhardinger, T. Hoehn, A. Adeboje, and M. Lorenzi
A Role for the Polyol Pathway in the Early Neuroretinal Apoptosis and Glial Changes Induced by Diabetes in the Rat
Diabetes, February 1, 2003; 52(2): 506 - 511.
[Abstract] [Full Text] [PDF]


Home page
IOVSHome page
R. Naskar, M. Wissing, and S. Thanos
Detection of Early Neuron Degeneration and Accompanying Microglial Responses in the Retina of a Rat Model of Glaucoma
Invest. Ophthalmol. Vis. Sci., September 1, 2002; 43(9): 2962 - 2968.
[Abstract] [Full Text] [PDF]


Home page
Br. J. Ophthalmol.Home page
J M Lopes de Faria, H Russ, and V P Costa
Retinal nerve fibre layer loss in patients with type 1 diabetes mellitus without retinopathy
Br. J. Ophthalmol., July 1, 2002; 86(7): 725 - 728.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
M. Nakamura, A. J. Barber, D. A. Antonetti, K. F. LaNoue, K. A. Robinson, M. G. Buse, and T. W. Gardner
Excessive Hexosamines Block the Neuroprotective Effect of Insulin and Induce Apoptosis in Retinal Neurons
J. Biol. Chem., November 16, 2001; 276(47): 43748 - 43755.
[Abstract] [Full Text] [PDF]


Home page
IOVSHome page
M. J. Gastinger, A. J. Barber, S. A. Khin, C. S. McRill, T. W. Gardner, and D. W. Marshak
Abnormal Centrifugal Axons in Streptozotocin- Diabetic Rat Retinas
Invest. Ophthalmol. Vis. Sci., October 1, 2001; 42(11): 2679 - 2685.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2000 by the Association for Research in Vision and Ophthalmology